🌙
PCSK9
News and stories about PCSK9
2 stories • Updated Nov 10, 2025
Health
Merck's Oral PCSK9 Inhibitor Achieves 55.8% LDL-C Reduction in Clinical Trial
14 sources
•
Nov 8, 2025
Health
"Amgen's Repatha Cuts Heart Attack Risk by 25% in Key Clinical Trial"
11 sources
•
Nov 8, 2025